郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor.

期刊：PloS one发表年份：2013作者：Arhamatoulaye Maïga; Jon Merlin; Elodie Marcon; Céline Rouget; Maud Larregola; Bernard Gilquin; Carole Fruchart-Gaillard; Evelyne Lajeunesse; Charles Marchetti; Alain Lorphelin; Laurent Bellanger; Roger J Summers; Dana S Hutchinson; Bronwyn A Evans;
阅读更多 →

药效评价Synthesis and pharmacological evaluation of a series of the agomelatine analogues as melatonin MT1 /MT2 agonist and 5-HT2C antagonist.

期刊：ChemMedChem发表年份：2013作者：Mohamed Ettaoussi; Ahmed Sabaouni; Basile Pérès; Elodie Landagaray; Olivier Nosjean; Jean A Boutin; Daniel-Henri Caignard; Philippe Delagrange; Pascal Berthelot; Saïd Yous
阅读更多 →

药效评价Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.

期刊：Journal of medicinal chemistry发表年份：2013作者：László Végner; Ágnes Peragovics; László Tombor; Balázs Jelinek; Pál Czobor; Andreas Bender; Zoltán Simon; András Málnási-Csizmadia
阅读更多 →

药效评价1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.

期刊：Bioorganic & medicinal chemistry发表年份：2013作者：Pierre Koch; Rhalid Akkari; Andreas Brunschweiger; Thomas Borrmann; Miriam Schlenk; Petra Küppers; Meryem Köse; Hamid Radjainia; Jörg Hockemeyer; Anna Drabczyńska; Katarzyna Kieć-Kononowicz; Christa E Müller
阅读更多 →